430 related articles for article (PubMed ID: 22997455)
1. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Peters S; Adjei AA; Gridelli C; Reck M; Kerr K; Felip E;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii56-64. PubMed ID: 22997455
[No Abstract] [Full Text] [Related]
2. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
[No Abstract] [Full Text] [Related]
3. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
Felip E; Stahel RA; Pavlidis N;
Ann Oncol; 2005; 16 Suppl 1():i28-9. PubMed ID: 15888743
[No Abstract] [Full Text] [Related]
4. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Crinò L; Weder W; van Meerbeeck J; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v103-15. PubMed ID: 20555058
[No Abstract] [Full Text] [Related]
5. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Reck M; Popat S; Reinmuth N; De Ruysscher D; Kerr KM; Peters S;
Ann Oncol; 2014 Sep; 25 Suppl 3():iii27-39. PubMed ID: 25115305
[No Abstract] [Full Text] [Related]
6. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Vansteenkiste J; De Ruysscher D; Eberhardt WE; Lim E; Senan S; Felip E; Peters S;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi89-98. PubMed ID: 23860613
[No Abstract] [Full Text] [Related]
7. Non-small cell lung cancer: issues in diagnosis, staging and treatment.
Harwood KV
Semin Oncol Nurs; 1987 Aug; 3(3):183-93. PubMed ID: 3039637
[No Abstract] [Full Text] [Related]
8. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv192-iv237. PubMed ID: 30285222
[No Abstract] [Full Text] [Related]
9. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Sørensen M; Pijls-Johannesma M; Felip E;
Ann Oncol; 2010 May; 21 Suppl 5():v120-5. PubMed ID: 20555060
[No Abstract] [Full Text] [Related]
10. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
ESMO.
Ann Oncol; 2001 Aug; 12(8):1049-50. PubMed ID: 11583180
[No Abstract] [Full Text] [Related]
11. Oligometastatic non-small cell lung cancer: Where do we go next?
Malik N; Palma D
Lung Cancer; 2017 Apr; 106():145-147. PubMed ID: 28062090
[No Abstract] [Full Text] [Related]
12. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman J; Chirieac LR; D'Amico TA; DeCamp MM; Dilling TJ; Dobelbower M; Doebele RC; Govindan R; Gubens MA; Hennon M; Horn L; Komaki R; Lackner RP; Lanuti M; Leal TA; Leisch LJ; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Stevenson J; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
J Natl Compr Canc Netw; 2017 Apr; 15(4):504-535. PubMed ID: 28404761
[TBL] [Abstract][Full Text] [Related]
13. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
Bunn PA
Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Verslype C; Rosmorduc O; Rougier P;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii41-8. PubMed ID: 22997453
[No Abstract] [Full Text] [Related]
15. Non-small-cell lung cancer: then and now.
Schiller JH; Gandara DR; Goss GD; Vokes EE
J Clin Oncol; 2013 Mar; 31(8):981-3. PubMed ID: 23401450
[No Abstract] [Full Text] [Related]
16. [Bronchial cancer: the initial assessment and therapeutic principles].
Lemarié E
Pneumoftiziologia; 1991; 40(4):19-25. PubMed ID: 1668795
[No Abstract] [Full Text] [Related]
17. Recent trends in the treatment of unresectable stage III non-small-cell lung cancer.
Makimoto G; Hotta K; Kiura K
Respir Investig; 2019 Jul; 57(4):330-336. PubMed ID: 31000495
[TBL] [Abstract][Full Text] [Related]
18. Combined modality treatment for locally advanced non-small cell lung cancer--which control arm?
Johnson DH
Lung Cancer; 1994 Mar; 10 Suppl 1():S231-8. PubMed ID: 7522113
[TBL] [Abstract][Full Text] [Related]
19. [35th Congress of the American Society of Clinical Oncology, Atlanta, USA, 15-18 May 1999. Non-small-cell lung tumors].
Foggi P
Clin Ter; 1999; 150(3):181-6. PubMed ID: 10528429
[No Abstract] [Full Text] [Related]
20. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B
Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
